Marker Therapeutics's total assets for Q3 2025 were $21.73M, an increase of 47.18% from the previous quarter. MRKR total liabilities were $3.35M for the fiscal quarter, a -21.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.